EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

28 hedge funds and large institutions have $24.4M invested in Eagle Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.1M
2
+$3.63M
3
+$2.67M
4
WSA
Wall Street Associates
California
+$2.55M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$2.27M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.1M
2
$3.63M
3
$2.67M
4
$2.55M
5
$2.27M
6
$1.97M
7
$1.61M
8
$1.27M
9
$1M
10
$364K
11
$348K
12
$291K
13
$271K
14
$175K
15
$164K
16
$147K
17
$138K
18
$134K
19
$110K
20
$78K
21
$43K
22
$17K
23
$13K
24
$10K
25
$9K
1
2